piper glp-1 reviews and complaints Weight Loss Review: Here's What I Think 1 medications or looking to feel their best every day. GLP-1 Medications: What Employers Should

In the United States, approximately 42% of adults have obesity [2], and obesity-related costs are estimated at $173 billion annually [3]

In addition, a large-scale clinical study demonstrated that GLP-1 analogues could reduce the mortality of patients with prostate cancer and diabetes (19)

Goktas SB, Manukyan M, Selimen D

There is no direct equivalent chart of GLP-1 medications

"By studying Ro's real-world, de-identified data we can generate insights that help us build tools that empower patients to overcome barriers to care and get more personalized support, laying the groundwork for broader access as innovators like Amgen bring the next generation of medicines to people living with obesity and related conditions." As GLP-1s help to transform the obesity treatment landscape, insurance coverage for the medications has remained a key hurdle for patients and providers